Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

Spano, 2008, AIDS-related malignancies: state of the art and therapeutic challenges, J Clin Oncol, 26, 4834, 10.1200/JCO.2008.16.8252 Deeks, 2009, HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity, BMJ, 338, 288, 10.1136/bmj.a3172 Silverberg, 2007, AIDS-defining and non-AIDS-defining malignancies: cancer occurence in the antiretroviral era, Curr Opin Oncol, 19, 446, 10.1097/CCO.0b013e3282c8c90d Patel, 2008, Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003, Ann Intern Med, 148, 728, 10.7326/0003-4819-148-10-200805200-00005 Engels, 2008, Cancer risk in people infected with human immunodeficiency virus in the United States, Int J Cancer, 123, 187, 10.1002/ijc.23487 Crum-Cianflone, 2009, Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study, AIDS, 23, 41, 10.1097/QAD.0b013e328317cc2d Herida, 2003, Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients, J Clin Oncol, 21, 3447, 10.1200/JCO.2003.01.096 Clifford, 2005, Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy, J Natl Cancer Inst, 16, 425, 10.1093/jnci/dji072 Grulich, 2007, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis, Lancet, 370, 59, 10.1016/S0140-6736(07)61050-2 Grabar, 2000, Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy, Ann Intern Med, 133, 401, 10.7326/0003-4819-133-6-200009190-00007 Lanoy, 2008, AIDS and non-AIDS defining malignancies in HIV-infected patients: the 2006 ONCOVIH French study, Antivir Ther, 13, A17 Burnham, 1998 Bonnet, 2009, Changes in cancer mortality among HIV-infected patients: the mortality 2005 survey, Clin Infect Dis, 48, 633, 10.1086/596766 Silverberg, 2009, HIV infection and the risk of cancers with and without a known infectious cause, AIDS, 10.1097/QAD.0b013e3283319184 Piketty, 2008, Marked increased in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy, AIDS, 22, 1203, 10.1097/QAD.0b013e3283023f78 Lanoy, 2007, Frequency, determinants and consequences of delayed access to care for HIV infection in France, Antivir Ther, 12, 89, 10.1177/135965350701200111 Franceschi, 2006, Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss Cohort Study, Br J Cancer, 95, 1598, 10.1038/sj.bjc.6603472 2008, HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS defining malignancies, AIDS, 22, 2143, 10.1097/QAD.0b013e3283112b77 Marin, 2009, Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy, AIDS, 23, 1743, 10.1097/QAD.0b013e32832e9b78 Schulz, 2009, Cancer and viral infections in immunocompromised indivuduals, Int J Cancer, 125, 1755, 10.1002/ijc.24741 Zoufaly, 2009, Cumulative HIV viremia during highly active retroviral therapy is a strong predictor of AIDS-related lymphoma, J Infect Dis, 200, 79, 10.1086/599313 Bruyand, 2009, Role of uncontrolled HIV RNA level and immunodeficiency in the occurence of malignancy in HIV infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le SIDA (ANRS) CO3 Aquitaine Cohort, Clin Infect Dis, 49, 1109, 10.1086/605594 Dieu-Nosjean, 2008, Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures, J Clin Oncol, 26, 4410, 10.1200/JCO.2007.15.0284 Franceschi, 2008, Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy, Br J Cancer, 99, 800, 10.1038/sj.bjc.6604520 Polesel, 2008, Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after higly active antiretroviral therapy, AIDS, 22, 301, 10.1097/QAD.0b013e3282f2705d Silverberg, 2007, Risk of cancers during interrupted antiretroviral therapy in the SMART study, AIDS, 21, 1957, 10.1097/QAD.0b013e3282ed6338 Di Lorenzo, 2007, Management of AIDS-related Kaposi's sarcoma, Lancet Oncol, 8, 167, 10.1016/S1470-2045(07)70036-0 Kuller, 2008, Inflammatory and coagulation biomarkers and mortality in patients with HIV infection, PLoS Med, 5, e203, 10.1371/journal.pmed.0050203 Reekie J, Mocroft A, Engsig F, et al. Relationship between current level of immunodeficiency and non-AIDS defining maligancies. 16th conference on retrovirus and opportunistic infections; Montreal; Feb 8–11, 2009. Abstr 860a. Biggar, 2006, Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS, Blood, 108, 3786, 10.1182/blood-2006-05-024109 Levine, 2006, Hodgkin lymphoma: to the HAART of the matter, Blood, 108, 3630, 10.1182/blood-2006-09-047498 Cadranel, 2006, Lung cancer in HIV infected patients: facts, questions and challenges, Thorax, 61, 1000, 10.1136/thx.2005.052373 Powles, 2009, Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection, J Clin Oncol, 27, 884, 10.1200/JCO.2008.19.6626 Palefsky, 2003, Immunosuppression and co-infection with HIV, J Natl Cancer Inst Monogr, 31, 41, 10.1093/oxfordjournals.jncimonographs.a003481